Precipio, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Precipio, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.05M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $18.53M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $15.20M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $9.41M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $8.85M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $6.09M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $3.13M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $2.86M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.72M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $1.72M | Apr 13, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.25M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $18.58M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $15.42M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $9.82M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $8.70M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $7.43M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $4.10M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $3.45M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.03M | Apr 16, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $1.56M | Apr 13, 2017 |
| FY2016 | Dec 31, 2015 | $1.93M | Apr 13, 2017 |
| FY2014 | Dec 31, 2014 | $7.70M | Apr 15, 2015 |
| FY2014 | Sep 30, 2014 | $6.37M | Apr 15, 2015 |
| FY2014 | Jun 30, 2014 | $6.76M | Apr 15, 2015 |
| FY2014 | Mar 31, 2014 | $6.25M | Apr 15, 2015 |
| FY2014 | Dec 31, 2013 | $6.22M | Apr 15, 2015 |
| FY2014 | Sep 30, 2013 | $6.65M | Apr 15, 2015 |
| FY2014 | Jun 30, 2013 | $7.31M | Apr 15, 2015 |
| FY2014 | Mar 31, 2013 | $7.37M | Apr 15, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.71M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $7.56M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $6.02M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $2.51M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.39M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $1.15M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $219.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $225.0K | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $292.0K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $753.0K | Apr 13, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($363.0K) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($4.29M) | Mar 30, 2026 |
| FY2019 | Dec 31, 2019 | ($13.24M) | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | ($15.69M) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($20.69M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($2.23M) | Apr 13, 2018 |
| FY2016 | Sep 30, 2016 | ($6.19M) | Apr 13, 2017 |
| FY2016 | Jun 30, 2016 | ($4.26M) | Apr 13, 2017 |
| FY2016 | Mar 31, 2016 | ($3.26M) | Apr 13, 2017 |
| FY2016 | Dec 31, 2015 | ($32.95M) | Apr 13, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.20M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($4.22M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($7.62M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($12.80M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($9.61M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($9.15M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($10.99M) | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($13.91M) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($15.51M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($1.71M) | Apr 13, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.60M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $1.30M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $1.70M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.70M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.30M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $1.20M | Mar 30, 2022 |
| FY2019 | Dec 31, 2019 | $1.20M | Mar 27, 2020 |
| FY2019 | Dec 31, 2018 | $1.10M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $500.0K | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Apr 13, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $10.30M | Mar 29, 2021 |
| FY2020 | Dec 31, 2019 | $9.62M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $9.45M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $6.49M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $2.47M | Apr 13, 2018 |
| FY2016 | Dec 31, 2015 | $7.06M | Apr 13, 2017 |
| FY2015 | Dec 31, 2014 | $7.39M | Apr 14, 2016 |
| FY2014 | Dec 31, 2013 | $23.30M | Apr 15, 2015 |
| FY2014 | Dec 31, 2012 | $20.15M | Apr 15, 2015 |
| FY2013 | Dec 31, 2011 | $19.15M | Mar 27, 2014 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $685.0K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $439.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($3.56M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($7.72M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($6.58M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($7.43M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($9.14M) | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($6.75M) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($6.69M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($959.0K) | Apr 13, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $326.0K | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $223.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $126.0K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $277.0K | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $682.0K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $151.0K | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $55.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $97.0K | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $143.0K | Apr 16, 2019 |
| FY2016 | Dec 31, 2016 | $19.0K | Apr 13, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.32M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $17.00M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $18.10M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $21.50M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $30.44M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $20.71M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $19.51M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $21.61M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $27.26M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $842.0K | Apr 13, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.76M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $4.90M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $3.67M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $5.14M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $5.84M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $6.55M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $6.31M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $15.48M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $14.24M | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | $7.30M | Apr 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $14.43M | Mar 29, 2024 |
| FY2023 | Dec 31, 2022 | $16.30M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $24.56M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $14.14M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $13.21M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $6.12M | Mar 27, 2020 |
| FY2019 | Dec 31, 2017 | $13.03M | Mar 27, 2020 |
| FY2018 | Dec 31, 2016 | ($6.46M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2015 | ($2.10M) | Apr 13, 2018 |
| FY2016 | Dec 31, 2014 | $6.55M | Apr 13, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2017 | $4.69M | Apr 16, 2019 |
| FY2014 | Dec 31, 2014 | $6.92M | Apr 15, 2015 |
| FY2014 | Dec 31, 2013 | $6.92M | Apr 15, 2015 |
| FY2014 | Dec 31, 2012 | $6.92M | Apr 15, 2015 |
| FY2013 | Dec 31, 2011 | $6.44M | Mar 27, 2014 |
| FY2012 | Dec 31, 2010 | $6.28M | Mar 14, 2013 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($102.80M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($102.44M) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | ($98.15M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($92.30M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($80.09M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($71.56M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($60.94M) | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($47.70M) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($31.54M) | Apr 16, 2019 |
| FY2017 | Dec 31, 2016 | ($10.85M) | Apr 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.65M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $1.39M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $1.50M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $3.45M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $11.67M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $2.66M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $848.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $381.0K | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $421.0K | Apr 16, 2019 |
| FY2018 | Dec 31, 2016 | $51.0K | Apr 16, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $83.0K | Mar 30, 2026 |
| FY2024 | Dec 31, 2024 | $383.0K | Mar 27, 2025 |
| FY2023 | Dec 31, 2023 | $353.0K | Mar 29, 2024 |
| FY2022 | Dec 31, 2022 | $404.0K | Mar 30, 2023 |
| FY2020 | Dec 31, 2020 | $1.03M | Mar 29, 2021 |
| FY2019 | Dec 31, 2019 | $543.0K | Mar 27, 2020 |
| FY2018 | Dec 31, 2018 | $516.0K | Apr 16, 2019 |
| FY2017 | Dec 31, 2017 | $3.42M | Apr 13, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | (4) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | (10) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 30, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | (4) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | (10) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 30, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.78M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 1.49M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 1.42M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 1.14M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 22.71M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 17.58M | Mar 30, 2022 |
| FY2020 | Mar 26, 2020 | 8.87M | Mar 29, 2021 |
| FY2020 | Dec 31, 2019 | 7.90M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | 2.30M | Mar 27, 2020 |
| FY2020 | Sep 6, 2018 | 1.54M | Mar 29, 2021 |